Evidence map›Paper›PMID 27771794›Full record

ArticleGlycoconjugate journal2017

An integrated approach using orthogonal analytical techniques to characterize heparan sulfate structure.

Daniela Beccati, Miroslaw Lech, Jennifer Ozug, Nur Sibel Gunay, Jing Wang, Elaine Y Sun, Joël R Pradines, Victor Farutin, Zachary Shriver, Ganesh V Kaundinya and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Glycoconjugate journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Analysis of the Glycosaminoglycan Chains of Proteoglycans.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2021
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Daniela BeccatiMomenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge, MA, 02142, USA.
Miroslaw LechMomenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge, MA, 02142, USA.
Jennifer OzugMomenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge, MA, 02142, USA.
Nur Sibel GunayMomenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge, MA, 02142, USA.
Jing WangMomenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge, MA, 02142, USA.
Elaine Y SunMomenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge, MA, 02142, USA.
Joël R PradinesMomenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge, MA, 02142, USA.
Victor FarutinMomenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge, MA, 02142, USA.
Zachary ShriverMomenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge, MA, 02142, USA.
Ganesh V KaundinyaMomenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge, MA, 02142, USA.
Ishan CapilaMomenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge, MA, 02142, USA. icapila@momentapharma.com.
Momenta Pharmaceuticals (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heparan sulfate (HS), a glycosaminoglycan present on the surface of cells, has been postulated to have important roles in driving both normal and pathological physiologies. The chemical structure and sulfation pattern (domain structure) of HS is believed to determine its biological function, to vary across tissue types, and to be modified in the context of disease. Characterization of HS requires isolation and purification of cell surface HS as a complex mixture. This process may introduce additional chemical modification of the native residues. In this study, we describe an approach towards thorough characterization of bovine kidney heparan sulfate (BKHS) that utilizes a variety of orthogonal analytical techniques (e.g. NMR, IP-RPHPLC, LC-MS). These techniques are applied to characterize this mixture at various levels including composition, fragment level, and overall chain properties. The combination of these techniques in many instances provides orthogonal views into the fine structure of HS, and in other instances provides overlapping / confirmatory information from different perspectives. Specifically, this approach enables quantitative determination of natural and modified saccharide residues in the HS chains, and identifies unusual structures. Analysis of partially digested HS chains allows for a better understanding of the domain structures within this mixture, and yields specific insights into the non-reducing end and reducing end structures of the chains. This approach outlines a useful framework that can be applied to elucidate HS structure and thereby provides means to advance understanding of its biological role and potential involvement in disease progression. In addition, the techniques described here can be applied to characterization of heparin from different sources.

Indexed as

AnimalsCattleChromatography, LiquidHeparan SulfateMass SpectrometryHeparan SulfateAnalyticalDomainsHeparan sulfateHPLCMSNMRStructure

Identifiers

PMID27771794
PMCPMC5266780
OpenAlexW2538841167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.